Search bioRxiv⌕ Search

Biology subjects

Lloyd, R.

Publications and source records attributed to Lloyd, R..

2 recordsLinked to original sources

Biomechanics of yawning: insights into cranio-cervical fluid dynamics and kinematic consistency

Yawning is a stereotyped orofacial-respiratory behaviour whose physiological role remains uncertain. Because cerebrospinal fluid (CSF) movement contributes to solute transport and waste removal and is strongly influenced by respiratory pressure dynamics, the study evaluated whether yawning alters neurofluid flow relative to normal and deep breathing, and whether yawning kinematics are reproducible within individuals. In a single MRI session in healthy adults, real-time phase-contrast imaging at the upper cervical level (C3) was combined with mid-sagittal real-time cine imaging to quantify CSF and internal jugular venous flows during normal breathing, forceful oral inspirations (deep breaths), yawns, and stifled yawns, and to derive tongue-motion trajectories. Both deep breaths and yawns increased CSF and venous flow compared with normal breathing; despite similar flow magnitudes, yawns more frequently produced co-directional caudal CSF and jugular outflow during inspiration, whereas deep breaths typically showed counter-directional CSF-venous flow. Yawning kinematics were highly reproducible within individuals across repeated events, indicating a stable motor sequence consistent with brainstem pattern-generator control. These observations show that yawning is not simply an intensified breath but a distinct cardiorespiratory manoeuvre that reorganizes neurofluid flow. The inspiratory alignment of CSF with venous outflow during yawns suggests a transient caudal advection that could influence solute transport and heat exchange within the cranial-cervical system, motivating targeted mechanistic studies with simultaneous airway pressure, thoraco-abdominal motion, and cervical venous pressure measurements.

physiology↗

ACE2 and SARS-CoV-2 Expression in the Normal and COVID-19 Pancreas

Diabetes is associated with increased mortality from Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). Given literature suggesting a potential association between SARS-CoV-2 infection and diabetes induction, we examined pancreatic expression of the key molecule for SARS-CoV-2 infection of cells, angiotensin-converting enzyme-2 (ACE2). Specifically, we analyzed five public scRNAseq pancreas datasets and performed fluorescence in situ hybridization, Western blotting, and immunolocalization for ACE2 with extensive reagent validation on normal human pancreatic tissues across the lifespan, as well as those from coronavirus disease 2019 (COVID-19) patients. These in silico and ex vivo analyses demonstrated pancreatic expression of ACE2 is prominent in pancreatic ductal epithelium and the microvasculature, with rare endocrine cell expression of this molecule. Pancreata from COVID-19 patients demonstrated multiple thrombotic lesions with SARS-CoV-2 nucleocapsid protein expression primarily limited to ducts. SARS-CoV-2 infection of pancreatic endocrine cells, via ACE2, appears an unlikely central pathogenic feature of COVID-19 as it relates to diabetes.

pathology↗